跳至主要内容
临床试验/NCT06810011
NCT06810011招募中不适用

EyeMatics - Eye Diseases "Treated" with Interoperable Medical Informatics

University Hospital Muenster6 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2024年3月1日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
2,000
试验地点
6
主要终点
Medical success

研究概览

简要总结

The overarching goal of EyeMatics is to promote an interoperable, sustainable infrastructure for the integration and sharing of data from clinical research to improve personalized medicine in ophthalmology. To achieve this, EyeMatics bundles the expertise and preliminary work of the four consortia of the Medical Informatics Initiative (MII) and the ophthalmological centers of excellence in Germany. The perspective and concerns of patients will be strongly incorporated into the project work through close cooperation with patient representatives and the inclusion of patient feedback on quality of life and treatment success.

EyeMatics aims to improve the understanding of the therapeutic success of eye diseases that are usually treated with intravitreal surgical medication (IVOM). To this end, an exemplary analysis platform for "real" clinical data will be provided and a dashboard for data visualization and analysis will be developed as a web application. The dashboard is to be introduced at all participating hospital sites for research purposes.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • OPS code: "5-156.9 Injection of drugs into the posterior segment of the eye"

排除标准

  • 未提供

结局指标

主要结局

Medical success

时间窗: with every treatment or controll-visit within 12, 24 and 36 months

changes in visual acuity during the course of treatment

次要结局

  • Treatment latency period:(from indication to treatment begin (Depending on the treatment regimen, assessed up to 6 months))
  • Treatment and monitoring frequency(during the procedure)
  • Treatment adherence(during the procedure)
  • Treatment persistence(during the procedure)
  • Patient-relevant outcomes (PROMs)(every 6 months within 12, 24 and 36 months)

研究者

发起方
University Hospital Muenster
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nicole Eter

Univ.-Prof. Dr. med. Nicole Eter

University Hospital Muenster

研究点 (6)

Loading locations...

相似试验